MedTrace Logo

The Effect of AC-134 in Chronic Kidney Diseases

NCT06441435 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2024-06-04

No results posted yet for this study

Summary

The objective is to explore the effects of adding AC-134 on renal function, proteinuria, uremic toxins, and metabolism-related markers in chronic kidney disease.

Conditions

  • Nephrology

Interventions

DIETARY_SUPPLEMENT

Low protein diet with AC-134

Low protein diet combined with AC-134 Dosage: 2 capsules,three times/day

OTHER

Standard treatment

Low protein diet

Sponsors & Collaborators

  • All Clean Health Co., Ltd

    collaborator UNKNOWN

  • Taichung Veterans General Hospital

    lead OTHER

Principal Investigators

  • Cheng-Hsu Chen, MDPHD · Division of Nephrology in Taichung Veterans General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-24
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06441435 on ClinicalTrials.gov